The states are increasingly struggling to cover the rising costs of popular GLP 1 medication such as Wegovy, Ozempic and Zepbound to search for ways to get out under the budget squeezer that surprised them.
A solution that some political decision-makers can try out is the restriction of the number of people to Medicaid who can employ the high-priced diabetes medication for weight loss purposes.
The medicaid cover of the medication in Pennsylvania is expected to cost $ 1.3 billion a few years ago in 2025 and contributes to projections of a budget deficit of several million dollar budget. The state thinks that Medicaid patients who want to employ GLP-1 to meet a certain number in the body mass index, or first try out a diet and training programs or cheaper medication.
“It is a medication that has received a lot of hype and a lot of press and has become very popular in its use and it is very expensive,” said Dr. Val Arkoosh, secretary for human services in Pennsylvania, in March a hearing of the state house.
At least 14 countries already cover the cost of GLP-1 medication for the treatment of obesity in patients on Medicaid, the Federal Health Program for People with Low Income. Democrats and Republicans in at least half a dozen other countries have requested the same cover this year, according to an associated press analysis using the Bill tracking software plural.
Some invoices have stalled, while others remain alive, including a proposal in Arkansas, in which GLP-1 must be covered under Medicaid if they are specially prescribed for weight loss. Iowa legislators think about ordering a cost-benefit analysis before they have undertaken. Already in West Virginia and North Carolina, the programs ended in 2024, which provided the employees of the national workers in relation to cost concerns.
“It is very expensive,” said Jeffrey Beckham, the state budget director in Connecticut, where medicaid coverage of the medication can be completely scrapped due to weight loss. “Other states come to this conclusion and some private airlines.”
Overall, the expenditure for Medicaid for GLP-1 medication-proof part-time discounts of pharmaceutical manufacturers from $ 577.3 million rose to $ 3.9 billion in 2023 in 2019. This is based on a November report from KFF, a non-profit organization, which examines health care problems. The number of recipes for the medicines rose by more than 400%in the same period. According to a Peterson KFF tracker, the average annual costs per patient for an GLP 1 medication are $ 12,000.
About half of the Americans “strong” or “somewhat” prefers Medicare and Medicaid, who cover weight loss medication for people with obesity, showed a recently carried out AP-NORC survey.
But Medicare does not cover GLP-1, and the Trump administration said on Friday that it does not employ a proposed rule of the president’s predecessor Joe Biden to cover the medication as part of the prescription medication coverage. Biden’s proposal was high-priced: it would have included coverage for all medical and state-financed Medicaid programs that cost taxpayers up to $ 35 billion in the next decade.
States that offer cover have tried to manage the costs by prescribing the GLP-1 regulations. There are also some indications that Medicaid patients, if they lose weight with the medication, are healthier and cheaper to cover, said Tracy Zvenyach from obesity action, a legal group that calls on the provision of insurance.
Zvenyach also emphasized how unclear whether patients have to take these medication regularly for the rest of their lives – an crucial cost concerns submitted by civil servants. “Someone may have to be treated in the course of their lives,” she said. “But we don’t know exactly what this regime would look like.”
According to the US centers for the control and prevention of diseases, around 40% of adults in the USA have obesity. Obesity can cause high blood pressure, type -2 -diabetes and high cholesterol levels, which leads to more risks of things such as stroke and heart attacks.
Dr. Adam Raphael Rome, a doctor at Greater Philadelphia Health Action, a network of health centers in the city, said most of his patients who take GLP-1 are covered by Medicaid, and some are non-diabetics who employ it for weight loss.
“I had a patient who told me that it was as if she had changed her relationship with food,” said Rome. “I lost patients like 20, 40, 60 pound.”
However, the Associated Press informed obesity experts that up to 1 out of 5 people may not lose the amount of weight that others have seen. In a state medicaid director that was recently carried out by KFF by KFF, a health guideline, which were recently carried out by KFF, they belonged to the fact that costs and potential side effects are concerned.
The debate on reporting is with increasing Medicaid budgets and the prospect of losing federal financing -with Republicans of the Congress, which will be received by Medicaid in the next decade of Medicaid.
Connecticut is exposed to a 290 million US dollar from Medicaid account deficit, and the democratic governor Ned Lamont suggested that Medicaid cover GLP-1 for grave obesity, although the state has never fully held back to the law.
From June 14th, however, state medicaid patients must have a diagnosis of type -2 diabetes in order to cover the medication. Lamont also urges the state to cover two cheaper high-priced oral drugs that were approved by the FDA for weight loss and nutritional advice.
Sarah Makoficki, 42, tried the other medication and said she had suffered grave side effects. The doctoral student and the office of the state house work on an invoice that restores the complete GLP 1 reporting for you and others.
Sara Lamontagne, a transgender woman with a disability that Medicaid has, said she had won the weight again when her cover for GLP-1 medication was cut off in the past. She said she was from £ 26 to over 300, heavier than ever.
“So, it is a terrible game to be played, to go back and gradually go,” said Lamontagne, whose attempts to appeal the recent refusal to refill the state.
Makoficki said GLP-1 medication in combination with weight loss surgery helped her to change her life: she had a knee replacement operation and lost over 200 pounds.
“I’m a person other than five years ago,” said Makoficki. “Not only in my physical space, but also mentally.”
___
Haigh reported from Hartford, Connecticut. Levy reported from Harrisburg, Pennsylvania.
